Giant cell myocarditis is a rare cause of cardiogenic shock requiring a high index of suspicion, rapid immunosuppressive therapy, and mechanical circulatory support. We present the case of a patient with giant cell myocarditis who underwent a successful bridge with four different types of mechanical circulatory support devices to heart transplantation.

JACC Editor-in-Chief 
Julia Grapsa, MD, PhD, FACC

CME Editor 
Nadeen N. Faza, MD, FACC

Authors
Yevgeniy Brailovsky, DO, MSC
Amirali Masoumi, MD
Rachel Bijou, MD
Estefania Oliveros, MD, MSC
Gabriel Sayer, MD
Koji Takeda, MD, PHD
Nir Uriel, MD, MSC

Important Dates

Date of Release: March 2, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: March 1, 2023